Mechanistically Based Blood Proteomic Markers in the TGF-β Pathway Stratify Risk of HCC in Patients With Cirrhosis
February 9, 2024
PRESS RELEASE: On February 5, 2024, a new research paper was published in Genes & Cancer, entitled, “Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis.” continue reading »